ArentFox Schiff: Oops, We Did It Again? Executive Action Revives Federal Marijuana Rescheduling Efforts and Sets Research and CBD Policy Priorities
On December 18, President Trump issued an executive order (EO) directing the Attorney General to complete rulemaking to reschedule “marijuana” from Schedule I to Schedule III under the Controlled Substances Act (CSA) and to expand federal research and policy...
DLA Piper: EO accelerates marijuana rescheduling and signals new federal framework for hemp-derived cannabinoids
EO accelerates marijuana rescheduling and signals new federal framework for hemp-derived cannabinoids Written by: Sharon Mayl Joshua Gardner President Donald Trump has issued an Executive Order (EO), “Increasing Medical Marijuana and Cannabidiol Research,” which...
Debvoise & Plimpton: Federal Cannabis Developments: Executive Order on Marijuana Rescheduling and New Risks for the CBD Industry
23 December 2025 Key Takeaways: On December 18, 2025, President Trump issued an executive order directing his administration to complete the process for reclassifying marijuana under the federal Controlled Substances Act, moving it from Schedule I to Schedule III. The...
Bradley: Trump Orders Marijuana Rescheduled, Broader CBD Access in Major Announcement: What Does It Mean?
By Whitt Steineker & Slates C. Veazey on December 23, 2025 Are you not entertained? In a much-anticipated ceremony in the Oval Office, President Trump signed an executive order that (1) directs the attorney general to expeditiously reschedule marijuana to Schedule...
Goodwin: Bye-Bye 280E: New Executive Order Concerning Cannabis Rescheduling
In a historic development, on December 18, 2025, President Donald Trump signed an Executive Order entitled “Increasing Medical Marijuana And Cannabidiol Research,” directing Attorney General Pam Bondi to “take all necessary steps to complete the rulemaking process...Top 200 Cannabis Lawyers
We Support